| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.74 | 0.006 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.27 | 6e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-12 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |